Overview
Damian Crowther holds the position of Expert Partner at Picus Capital [1][10]. Crowther's professional focus centers on discovering valuable neuroscience therapies, drawing on a background in basic, clinical and pharmaceutical neuroscience [2]. Crowther currently serves as Head of Research at TRIMTECH Therapeutics Limited [3], having previously held the positions of Founding CEO and Founder & Head of Research and Translational Sciences at the same organization [4][5]. Additional current roles include Entrepreneur In Residence at both the Dementia Discovery Fund and Cambridge Innovation Capital [6][8], Member of Parkinson's UK Drug Discovery Advisory Panel [7], and Honorary Associate Professor at UCL [9]. Crowther holds the qualifications FRCP in Medicine [11] and MRCP in Clinical Medicine [12], and completed a BM BCh in Clinical Medicine at the University of Oxford [13].
Profile introduction
With a background in basic, clinical and pharmaceutical neuroscience I am focused on discovering the next wave of valuable neuroscience therapies.
Career history
- Head of ResearchNov 2024 to presentTRIMTECH Therapeutics Limited
- Founder & Head of Research and Translational SciencesJan 2024 to Nov 2024TRIMTECH Therapeutics Limited
- Founding CEONov 2023 to Jan 2024TRIMTECH Therapeutics Limited
- Entrepreneur In ResidenceJun 2022 to presentDementia Discovery Fund (DDF)
- Member of Parkinson's UK Drug Discovery Advisory PanelJun 2022 to presentParkinson's UK
- Entrepreneur In ResidenceMay 2022 to presentCambridge Innovation Capital
- Honorary Associate ProfessorApr 2020 to presentUCL
- Expert PartnerJun 2023 to presentPicus Capital
Education
- FRCP, Medicine2020Royal College of Physicians (London))
- MRCP, Clinical Medicine1996 - 1997Royal College of Physicians (London))
BM BCh, Clinical Medicine1992 - 1995University of Oxford
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.